Summary
- Current Price
- As of today, CTNM price is $8.46, up +13.71% on
- Current Price All-Time High
- CTNM price is currently -61.55% below its historical high of $22.00 set on
- Market Cap
- CTNM current market cap is $318M, down -1.66% year-over-year
- Revenue
- CTNM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CTNM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Contineum Therapeutics, Inc. |
| Ticker | NASDAQ: CTNM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | contineum-tx.com |
| Employees | 41 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $8.46 | |
| Price, 1D Change | +13.71% | |
| $318M | ||
| - | ||
| - | ||
| 1.40 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.17 | ||
| EPS, 1Y Change | -32.48% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.17 | ||
| EPS Estimate | -$1.70 | N/A |
| EPS Est. Change | +21.68% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $8.46 | |
| Price Target | $22.00 | - |
| Price Tgt. Change | +160.05% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.90 | -$1.63 | +14.09% | |
| -$2.05 | -$2.17 | -5.47% | |
| -$1.70 | N/A | +21.68% | |
| -$1.93 | N/A | +11.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $5.00M | $0.00 | -100.00% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $8.46 | |
| $13.60 | ||
| $13.71 | ||
| $13.11 | ||
| $12.58 | ||
| -$1.72 | ||
| 1.40 | ||
| $1.18 | ||
| 33.10 | ||
| 209.36% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.17 | ||
| -$323.00K | ||
| - | ||
| -$68.06M | ||
| - | ||
| -$59.98M | ||
| - | ||
| -$67.74M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 27.50 | ||
| 27.50 | ||
| - | ||
| - | ||
| 10.39 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.33 | ||
| -1.34 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $260.99M | ||
| $262.90M | ||
| $278.38M | ||
| $267.92M | ||
| $17.39M | ||
| $9.74M | ||
| $8.25M | ||
| $2.34M | ||
| $1.02M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $59.98M | ||
| $67.74M | ||
| $323.00K | ||
| $0.00 | ||
| $323.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$55.31M | ||
| -$3.71M | ||
| $112.69M | ||
| $231.00K | ||
| -$55.54M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Jones Trading | → | |
| Baird | → | |
| Morgan Stanley | → | |
| Jones Trading | → | |
| Baird | → | |
| RBC Capital | → | |
| Morgan Stanley | → | |
| Baird | → | |
| Morgan Stanley | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with CTNM
FAQ
- What is the ticker symbol for Contineum Therapeutics, Inc.?
- The ticker symbol for Contineum Therapeutics, Inc. is NASDAQ:CTNM
- Does Contineum Therapeutics, Inc. pay dividends?
- No, Contineum Therapeutics, Inc. does not pay dividends
- What sector is Contineum Therapeutics, Inc. in?
- Contineum Therapeutics, Inc. is in the Healthcare sector
- What industry is Contineum Therapeutics, Inc. in?
- Contineum Therapeutics, Inc. is in the Biotechnology industry
- What country is Contineum Therapeutics, Inc. based in?
- Contineum Therapeutics, Inc. is headquartered in United States
- When did Contineum Therapeutics, Inc. go public?
- Contineum Therapeutics, Inc. initial public offering (IPO) was on April 4, 2024
- Is Contineum Therapeutics, Inc. in the S&P 500?
- No, Contineum Therapeutics, Inc. is not included in the S&P 500 index
- Is Contineum Therapeutics, Inc. in the NASDAQ 100?
- No, Contineum Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Contineum Therapeutics, Inc. in the Dow Jones?
- No, Contineum Therapeutics, Inc. is not included in the Dow Jones index
- When was Contineum Therapeutics, Inc. last earnings report?
- Contineum Therapeutics, Inc.'s most recent earnings report was on July 30, 2026
- When does Contineum Therapeutics, Inc. report earnings?
- The next expected earnings date for Contineum Therapeutics, Inc. is October 29, 2026
Data Sources & References
- CTNM Official Website www.contineum-tx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1855175/000162828026015165/0001628280-26-015165-index.htm
- CTNM Profile on Yahoo Finance finance.yahoo.com/quote/CTNM
- CTNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctnm